Bogota Financial Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bogota Financial Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($2.17M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $642.5K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $6.88M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $7.52M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.07M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $2.43M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $4.14M | Mar 30, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.20M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($2.56M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.44M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $10.86M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $5.96M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $5.80M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $2.57M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $4.18M | Mar 30, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.4K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $594.8K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $318.0K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $241.5K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.46M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.75M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $159.3K | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $523.9K | Mar 30, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $904.95M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $971.49M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $939.32M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $951.10M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $837.36M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $740.90M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $766.61M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $665.01M | Mar 30, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $764.04M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $834.20M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $802.15M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $811.44M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $689.79M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $612.44M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $691.63M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $592.53M | Mar 30, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140.91M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $137.29M | Mar 27, 2026 |
| FY2025 | Dec 31, 2023 | $137.17M | Mar 27, 2026 |
| FY2024 | Dec 31, 2022 | $139.66M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $147.58M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $128.47M | Mar 24, 2023 |
| FY2021 | Dec 31, 2019 | $74.98M | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $72.48M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $68.31M | Mar 30, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $92.10M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $90.01M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $92.18M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $91.76M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $84.88M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $77.36M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $75.29M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $72.79M | Mar 30, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.60M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $52.23M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $24.93M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $16.84M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $105.07M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | $80.39M | Mar 29, 2022 |
| FY2021 | Dec 31, 2019 | $127.86M | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $24.52M | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | $22.56M | Mar 30, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 29, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 29, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.93M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | 13.06M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | 13.28M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 13.70M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 14.61M | Mar 24, 2023 |
| FY2021 | Dec 31, 2020 | 13.16M | Mar 29, 2022 |